Diagnostic endoscopic investigations in lung cancer
نویسندگان
چکیده
Distinguishing nonsmall cell lung cancer (NSCLC) from small cell lung cancer (SCLC) is of paramount importance, since the treatment and prognosis of the cancers are often significantly different. SCLC is well known to exhibit massive lymphadenopathy, direct mediastinal invasion and paraneoplastic syndromes [1]. However, there is considerable clinical overlap between NSCLC and SCLC such that clinical differentiation is often not possible and pathological diagnosis is essential. A small number of patients who are unfit for any oncological or surgical treatment and are candidates for best supportive care only may not benefit from pathological diagnosis. In these patients, a clinical diagnosis of lung cancer may have to suffice on the basis of imaging alone. The remaining majority of patients undergo various investigations to determine the histological subtype. An initial diagnosis should be pursued from the most distal site of suspected disease in order to provide staging as well as diagnostic information. Cytology or histology may be provided for pathological analysis, depending on the source and technique employed to generate the sample. Either histology or cytology can discriminate NSCLC from SCLC. Although histology may generally be preferred, cytological samples are also reliable, particularly for NSCLC. Meta-analysis of data from sputum, bronchoscopy and transthoracic needle aspiration compared cytology to histology samples for patients with NSCLC and SCLC [2]. The probability of diagnosing NSCLC in error on the basis of cytology was 0.02 (range 0.01–0.07); however, the converse is less robust. A diagnosis of SCLC had a probability of actually being a NSCLC of 0.09 (range 0–0.33). Therefore, if a diagnosis of SCLC is made on a cytological sample, but the clinical and radiological findings are discordant with the cytological diagnosis, then a histological biopsy should be obtained where possible [2]. In order to achieve a tissue diagnosis of lung cancer, patients may undergo sputum cytology analysis, bronchoscopy, transbronchial needle aspiration (with or without endobronchial ultrasound guidance), endoscopic ultrasound fine needle aspiration, or surgical procedures; these are discussed below. Radiologically guided transthoracic sampling is discussed in chapter 7 in this European Respiratory Monograph.
منابع مشابه
Minimally invasive endoscopic staging for mediastinal lymphadenopathy in lung cancer: a systematic review protocol
INTRODUCTION Minimally invasive endoscopic biopsy techniques have been widely available as potential alternatives for mediastinal lesions staging in patients with known or suspected lung cancer. Previous efforts have been made to evaluate the diagnostic performance of specific endoscopic modality alone at the level of the mediastinum for staging lung cancer, however, few studies focus on the ac...
متن کاملA Comparison of Endoscopic Ultrasound Guided Biopsy and Positron Emission Tomography with Integrated Computed Tomography in Lung Cancer Staging
BACKGROUND AND STUDY AIMS Exact staging of patients with non-small-cell lung cancer (NSCLC) is important to improve selection of resectable and curable patients for surgery. Positron emission tomography with integrated computed tomography (PET/CT) and endoscopic ultrasound guided fine needle aspiration biopsy (EUS-FNA) are new and promising methods, but indications in lung cancer staging are co...
متن کاملInfluence of the Different Primary Cancers and Different Types of Bone Metastasis on the Lesion-based Artificial Neural Network Value Calculated by a Computer-aided Diagnostic System,BONENAVI, on Bone Scintigraphy Images
Objective(s): BONENAVI, a computer-aided diagnostic system, is used in bone scintigraphy. This system provides the artificial neural network (ANN) and bone scan index (BSI) values. ANN is associated with the possibility of bone metastasis, while BSI is related to the amount of bone metastasis. The degree of uptake on bone scintigraphy can be affected by the type of bone metastasis. Therefore, t...
متن کاملDetermination of Soluble HER-2/neu (sHER-2/neu) in Iranian Patients with Lung Cancer
Background: The HER-2/neu gene is located on chromosome 17q21 and encodes a 185-kDa transmembrane glycoprotein with tyrosine kinase activity reported to be released in soluble form in various malignancies. Objective: To evaluate the clinical significance of soluble Her-2/neu as a diagnostic marker in lung cancer. Methods: Serum levels of soluble HER-2/neu were measured in 43 patients with lung ...
متن کاملIdentification of a Novel Tumor-Binding Peptide for Lung Cancer Through in-vitro Panning
Tumor-targeted therapies are playing growing roles in cancer research. The exploitation of these powerful therapeutic modalities largely depends on the discovery of tumor-targeting ligands. Phage display has proven a promising high throughput screening tool for the identification of novel specific peptides with high binding affinity to cancer cells. In the present study, we describe the use of ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2009